Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

Novo Nordisk A/S1 site in 1 country381 target enrollmentOctober 2013

ConditionsCongenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors Haemophilia B Haemophilia B With Inhibitors

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Congenital Bleeding Disorder
Sponsor: Novo Nordisk A/S
Enrollment: 381
Locations: 1
Primary Endpoint: Prevalence of acute (bleed-related) pain (percentage)
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.

Registry

clinicaltrials.gov

Start Date

October 2013

End Date

October 2014

Last Updated

9 years ago

Study Type

Observational

Sex

Male

Investigators

Sponsor

Novo Nordisk A/S

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Adult males able to provide consent and complete a survey in English
•Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain
•Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained
•Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)